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Muscle repair relies on coordinated activation and diﬀerentiation of satellite cells, a process that is unable to counterbalance
progressive degeneration in sporadic inclusion body myositis (s-IBM). To explore features of myo regeneration, the expression of
myogenic regulatory factors Pax7, MyoD and Myogenin and markers of regenerating ﬁbers was analyzed by immunohistochemistry
in s-IBM muscle compared with polymyositis, dermatomyositis, muscular dystrophy and age-matched controls. In addition, the capillary
density and number of interstitial CD34+ hematopoietic progenitor cells was determined by double-immunoﬂourescence staining.
Satellite cells and regenerating ﬁbers were signiﬁcantly increased in s-IBM similar to other inﬂammatory myopathies and correlated with
the intensity of inﬂammation (R > 0.428). Expression of MyoD, visualizing activated satellite cells and proliferating myoblasts, was
lower in s-IBM compared to polymyosits. In contrast, Myogenin a marker of myogenic cell diﬀerentiation was strongly up-regulated
in s-IBM muscle. The microvascular architecture in s-IBM was distorted, although the capillary density was normal. Notably,
CD34+ hematopoietic cells were signiﬁcantly increased in the interstitial compartment. Our ﬁndings indicate profound myo-endothelial
remodeling of s-IBM muscle concomitant to inﬂammation. An altered expression of myogenic regulatory factors involved in satellite cell
activation and diﬀerentiation, however, might reﬂect perturbations of muscle repair in s-IBM.
2012 Elsevier B.V.
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Open access under CC BY-NC-ND license.50 years [1]. Recently, the prevalence rate of s-IBM, age
and sex-adjusted to the US census count in 2000, was esti-
mated at 7.06 cases per 100,000 [2]. The disease manifests
with progressive asymmetric weakness and atrophy of
proximal and distal limb muscles [3] that are resistant to
immunosuppressive treatment [4]. Current concepts on
the underlying pathogenic mechanisms of s-IBM have
focused on the unique combination of endomysial inﬂam-
mation [5,6] and myo-degeneration related to impaired
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related proteins [7] that delineate s-IBM from other inﬂam-
matory myopathies (IM) [8]. The understanding of trigger-
ing events and pathogenic pathways that confer muscle
ﬁber injury in s-IBM, however, remains incomplete [9].
Maintenance and repair of skeletal muscle relies mainly
on the proliferative potential of satellite cells (SCs), a dis-
tinct population of committed myogenic progenitors also
called adult muscle stem cells, that reside in sublaminal cell
niches attached to mature myoﬁbers [10]. In adult muscle,
SCs represent approximately 5% of the total myonuclei
[11,12] and remain in a quiescent state expressing the
paired box transcription factor Pax7, necessary for their
maintenance during postnatal life [13]. Muscle damage
activates SCs to proliferate, which subsequently diﬀerenti-
ate and form fusion-competent myoblasts in order to repair
or replace damaged muscle ﬁbers [11,14]. This highly coor-
dinated myogenic pathway is controlled by myogenic regu-
latory factors Myf5, Mrf4, MyoD, and Myogenin, a group
of nuclear transcription factors, which are sequentially
expressed during muscle regeneration [15]. Following myo-
blast fusion, emerging muscle ﬁbers transiently up-regulate
developmental proteins such as embryonic and neonatal
myosin heavy chains [15], the intermediate ﬁlament protein
vimentin [16] and neural cell adhesion molecule (NCAM)
that is widely expressed in SCs and regenerating as well
as denervated muscle ﬁbers [17]. Finally, maturation and
functional re-integration of newly regenerated ﬁbers criti-
cally depend on the reorganization of supporting structures
in the extracellular compartment [15] and suﬃcient revas-
cularization at the site of injury [18].
Muscle repair in s-IBM is unable to prevent progressive
loss of muscle ﬁbers, although induction of myogenesis has
been indicated by the observation of an increased number
of Pax7+ satellite cells [19] and regenerating ﬁbers re-
expressing developmental molecules in muscle biopsies
from a small number of s-IBM patients [16,20]. In vitro
studies, in contrast, demonstrated a reduced proliferation
rate of s-IBM myoblasts versus age-matched controls and
the authors proposed that a defective regeneration of s-
IBM muscle might be a contributory factor to the complex
pathophysiology of the disease [21]. The purpose of the
present study was to explore the in situ expression ofTable 1
Demographic data of patients.
Disease n Median age at biopsy Ra
sIBM* 39 67 y 40
PM 13 43 y 16
DM 13 44 y 17
MD 10 43 y 26
Co 10 64 y 55
Total 85
n = number of patients, y = years, m = months.
* Eleven patients with sIBM received a treatment with low-dose steroids (n =
biopsy. PM and DM patients had proximal limb weakness of less than 6 month
of Dalakas and Hohlfeld [25].myogenic regulatory factors, the frequency and distribu-
tion of regenerating ﬁbers and the pattern of microvascu-
larisation in muscle biopsies from a large series of
patients in order to analyze potential perturbations of the
myogenic program and consecutive tissue remodeling in
s-IBM skeletal muscle in an in vivo context. Results were
compared with polymyositis and dermatomyositis, muscu-
lar dystrophies and normal aged muscle and were related to
the age of patients, duration of the disease and to the extent
of inﬂammation.
2. Materials and methods
2.1. Patients and biopsy specimens
Medical and pathological records from all patients with
clinically suspected s-IBM who were seen at the Reference
Center for Neuromuscular Diseases, Institut de Myologie,
Hoˆpital Pitie´-Salpetrie`re [4] and the Division for Neuro-
muscular Diseases at the Department of Neurology, Inns-
bruck Medical University between 1999 and 2008 were
retrospectively reviewed. All patients had a muscle biopsy
for diagnostic purposes after written informed consent.
From 39 patients (19 females, 20 males) who fulﬁlled diag-
nostic criteria of deﬁnite s-IBM frozen muscle tissue stored
at 80 C was available for further analysis. Age at biopsy
and duration of disease did not diﬀer between male and
female patients. Clinically, a typical proximal and distal
asymmetric limb weakness was present in 34 patients, while
4 patients manifested with purely proximal and 1 patient
with purely distal motor deﬁcits at the time of biopsy; 21
patients developed dysphagia during the course of the dis-
ease. Eleven patients had received a treatment with either
low-dose steroids alone (n = 5) or combined with azath-
rioprine or methotrexate (n = 6) before biopsy. The
deﬁnitive diagnosis of s-IBM was based on established
clinico-pathological criteria [5,22] and sarcoplasmic immu-
noreactivity for b-amyloid, phosphorylated tau, p62 [23] or
TDP-43 protein [24] within >1% of muscle ﬁbers. For
comparison with other inﬂammatory myopathies, muscle
biopsies from patients referred to the Reference Center
for Neuromuscular Diseases, Institut de Myologie, Hoˆpital
Pitie´-Salpetrie`re who displayed treatment-responsivenge F/M Median duration Range
–89 y 19/20 54 m 6–198 m
–72 y 11/2 5 m 1–108 m
–79 y 9/4 4 m 1–8 m
–77 y 7/3
–74 y 5/5
5) or steroids combined with azathrioprine or methotrexate (n = 6) before
s duration with improvement after steroids, muscle biopsies fulﬁlled criteria
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ological criteria for dermatomyositis (DM, n = 13) or poly-
myositis (PM, n = 13) as proposed by Dalakas and
Hohlfeld [25] were analyzed. In addition, frozen muscle
tissue from muscular dystrophies (MD, n = 10; 3 dysferlin-
opathies, 3 calpainopathies, 1 Bethlem myopathy, 3 unspec-
iﬁed cases of limb girdle MD) as well as 10 individuals, who
underwent a muscle biopsy for diagnostic work-up of myal-
gia or fatigue but had no evidence of a myopathy, was
retrieved from the tissue bank of the Unite´ de Morphologie
Neuromusculaire, Institut de Myologie, and included in the
study for control purposes. Demographic data of patients
and controls are summarized in Table 1. The study was
approved by the local ethics committee of the Medical
University of Innsbruck, Austria (UN 3233_LEK) and
the Hoˆpital Pitie´-Salpeˆtrie`re, Paris, France.
2.2. Histological, enzyme histochemical, and
immunohistochemical analyses
Muscle specimens from s-IBM patients processed for
Gomori-Trichrome and Cytochrome-C-Oxidase reactions
and Congo-red stain were re-examined for the presence of
rimmed vacuoles, COX-negative ﬁbers and Congo-red posi-
tive inclusions. For immunohistochemistry, sections were
re-cut from stored frozen muscle (80 C), which comprised
deltoid, biceps brachii and quadriceps muscles in most
patients; in several s-IBM patients biopsy was performed
from extensor muscles of the forearm (n = 8) or tibialis ante-
rior muscle (n = 5). 8 mm thick cryo-sections were air-dried
and ﬁxed either in 4% formaldehyde (for MyoD,Myogenin,
and b-amyloid) at room temperature or in cold acetone at
20 C (for all other primary antibodies) for 10 min each.
After washing in phosphate buﬀered saline (PBS), sections
were incubated with 10% normal goat serum (G9023;
Sigma) in antibody diluent (S3022; Dako) for 30 min tomin-
imize unspeciﬁc binding. Primary antibodies (all mouse
monoclonal; except against TDP-43 and p62: rabbit poly-
clonal) were directed against MHC-I (1:1000, Dako), CD4
(1:500, Dako), CD8 (1:200, Dako), CD68 (1:1000; Dako),
phosphorylated tau (SMI-31; 1:1000; Covance), beta-
amyloid (b-A4; 1:50; Dako), TDP-43 (1:2000; Proteintech
Group), p62 (1:100; Santa Cruz Biotech), neuronal cell
adhesion molecule (NCAM) (CD56; clone 123C3.D5; Ven-
tana medical systems), vimentin (clone 3B4; Ventana medi-
cal systems), neonatal myosin (clone WB-MHCn; 1:20;
Novocastra), Pax7 (clone Pax7; 1:200; R&D systems),
MyoD (clone 5.8A; 1:100; BectonDickinson (BD) Pharmin-
gen) and Myogenin (clone F5D; 1:400; BD Pharmingen).
Staining for MyoD, Myogenin and beta-amyloid was per-
formed manually with incubation of primary antibodies
over-night at 4 C. Other stains were done with an auto-
mated immunostainer (BenchMark XT, Ventana medical
systems). Binding of primary antibodies was detected with
a peroxidase reaction and visualized with 3,30-
diaminobenzidine as chromogen (Dako Reale Detection
System (K5001; Dako) for manual stains; secondaryreagents from Ventana medical systems for automated
stains). For control purposes a mouse IgG1 isotype control
(BD Pharmingen) was used instead of primary monoclonal
mouse antibodies. Total IgG from rabbit serum (Sigma) was
used to control for non-speciﬁc staining of polyclonal rabbit
antibodies.
2.3. Fluorescence immunostaining
Density of capillaries and number of mononuclear inter-
stitial cells positive for CD34, a marker expressed on
mature endothelial cells as well as endothelial and hemato-
poietic progenitor cells [26], were assessed in 6 representa-
tive cases from each disease group and controls.
Acetone-ﬁxed cryo-sections were blocked with avidin/bio-
tin blocking reagent (SP-2001, Vector Laboratories) for
15 min, brieﬂy rinsed with PBS, exposed to 10% normal
goat serum for 30 min and then incubated overnight at
4 C with mouse monoclonal anti-CD34 (1:50; BD Pharm-
ingen) and rabbit polyclonal anti-laminin (1:400; Dako).
Further, sections from patients with s-IBM and PM and
from controls were incubated overnight with mouse
monoclonal anti-NCAM (IgG1; 1:20; Monosan) and rabbit
polyclonal anti-TDP-43 (1:1000; Proteintech Group).
Subsequently, sections were incubated with Alexa Fluor
(AF) 555 goat-anti-mouse IgG (L + H) and AF 488 goat-
anti-rabbit IgG (L + H) for 60 min at room temperature
(all diluted 1:400; Invitrogen). Puriﬁed mouse IgG1 (BD
Pharmingen) was included as an isotype control instead
of primary monoclonal antibodies and total IgG from
rabbit serum (Sigma) was used as control for polyclonal
antibodies. Double-stained samples were covered with
Vectashield mounting medium containing 40,6-diamidino-
2-phenylindole (DAPI) (H-1200; Vector Laboratories)
and analyzed using a ﬂourescence microscope (Leica
DFC300 FX).
2.4. Quantiﬁcation
In order to examine a relationship between inﬂammation
and myogenesis, the percentage of MHC-I positive muscle
ﬁbers and the extent of inﬂammatory cell inﬁltration were
evaluated semiquantitatively on the entire cross-sectional
area from eachmuscle biopsy; in all disease groups the diam-
eter of cross sections varied between 5–10 mm. For MHC-I,
grades 1–5 were applied when it was expressed on the sarco-
lemma of <10% (=1); 10–25% (=2); 25–75% (=3); 75–95%
(=4), and >95% (=5) of the myoﬁbers. CD4+ and CD8+
T-cell subsets and CD68+ mononuclear cells were graded
as: 1 = single, 2 = sparse, 3 = moderate, 4 = dense. The per-
centage of non-necrotic myoﬁbers immunoreactive for neo-
natal myosin, vimentin or NCAM and ﬁbers containing
cytoplasmic deposits of age-related proteins was determined
on serial sections by counting 200 ﬁbers in 20 randomly
selected ﬁelds with a 40 objective. In analogy, values for
Pax7+, MyoD+ and Myogenin+ nuclei were obtained as a
percentage of the total myonuclei. Numbers of CD34+
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mm2 were quantiﬁed in double-stained sections (CD34+/
laminin) using Metavue image analysis software (Universal
imaging, Downington, PA). Each biopsy was evaluated on
coded sections by two independent researches blinded to
the diagnosis; an average of the results was calculated and
entered into statistical analysis.
2.5. Statistical analysis
Data are expressed as median values with interquartile
range. Between-group comparisons of non-parametric data
were done with Kruskall–Wallis and Dunn’s multiple com-
parison post hoc tests. P values < 0.05 were considered sta-
tistically signiﬁcant. Spearmen bivariate correlation
analysis was performed to identify interdependence of vari-
ables. The inﬂuence of age, disease duration, sex and pre-
treatment on markers of regeneration in s-IBM muscle
was analyzed using a general multivariate model after nor-
malization of data. Statistical analysis was performed using
SPSS (release 18.0, SPSS Inc., USA).
3. Results
3.1. Characteristics of s-IBM muscle biopsies
All patients fulﬁlled the Griggs’ criteria for deﬁnite s-
IBM by the presence of endomysial inﬂammation and
mononuclear cell invasion of non-necrotic muscle ﬁbers,
vacuolated muscle ﬁbers and intracellular deposits of amy-
loid or related proteins (detected by electron microscopy
or immunohistochemical staining for b-amyloid, phosphor-
ylated tau, p62 or TDP-43 proteins), illustrated in Fig. 1A–
C. The degree of myo-pathological alterations, i.e. fre-
quency of rimmed vacuoles and congophilic deposits, extent
of muscle ﬁber atrophy and endomysial ﬁbrosis as well as
intensity of inﬂammation varied considerably between indi-
vidual patients. Evaluation of the percentage of MHC-I
expressing muscle ﬁbers and the extent of endomysial
inﬂammatory inﬁltration by CD4+ T-cells, CD8+ T-cells
and CD68+ monocytes/macrophages in s-IBM in compari-
son to other disease groups and controls is shown in Table 2.
3.2. Expression of myogenic regulatory factors and signs of
myo-regeneration
All IM subtypes displayed signiﬁcantly increased num-
bers of Pax7+ satellite cells and nuclei expressing MyoD
and Myogenin in comparison to controls (Fig. 2A–C).
Most Pax7+ satellite cells were closely attached to muscle
ﬁbers (Fig. 1D) and were particularly numerous at sites
of inﬂammation, although they were also found to be scat-
tered throughout the specimen. Nuclear expression of
MyoD and Myogenin was detectable in small round or
spindle-shaped myogenic cells and small-diameter muscle
ﬁbers that preferentially clustered in the vicinity of inﬂam-
matory lesions (Fig. 1E–G). Median values of Pax7+ SCsand Myogenin+ nuclei did not diﬀer between IM subtypes,
but MyoD+ nuclei were signiﬁcantly less numerous in
s-IBM than in PM (p = 0.016, Fig. 2B). The lower fre-
quency of MyoD+ nuclei in s-IBM contrasted with an
excessive increase of Myogenin+ nuclei (Fig. 2C). Unlike
PM, Myogenin+ nuclei in s-IBM were not conﬁned to sites
of active regeneration but were also seen in areas with
advanced ﬁbrosis within both atrophic and hypertrophic
ﬁbers, which occasionally displayed a vacuolization of the
cytoplasm (Fig. 1H).
In accordance with an increased expression of myogenic
regulatory factors, the number of regenerating ﬁbers
expressing neonatal myosin, vimentin or NCAMwas highly
elevated in IMs compared to controls (p < 0.0001, Fig. 2D–
F). Notably, early regenerating neonatal myosin+ and
vimentin+ muscle ﬁbers were numerous in s-IBM muscle in
areas of inﬂammation (Fig. 1I and J), but the number dimin-
ished in areas of ﬁber atrophy and endomysial ﬁbrosis result-
ing in overall lowermedianvalues of early regenerating ﬁbers
in s-IBM compared to PM (Fig. 2D and E). NCAM was
widely expressed by small-diameter, normal appearing or
hypertrophic muscle ﬁbers (Fig. 1K) as well as sublaminar
SCs (Fig. 1L) and mononuclear myogenic cells (Fig. 1M
and N). NCAM+ ﬁbers in s-IBM muscle excessively
accumulated with advanced myo-pathological alterations
and occasionally displayed sarcoplasmic deposits of TDP-
43 (Fig. 1O).
3.3. Clinico-pathological associations
The satellite cell number, expression of myogenic regula-
tory factors and frequency of regenerating ﬁbers signiﬁ-
cantly correlated with the percentage of MHC-I positive
muscle ﬁbers and the extent of inﬂammatory cell inﬁltra-
tion in all disease groups (R for all variables > 0.428;
p < 0.0001, exempliﬁed for Pax7 and CD68 in Fig. 2G).
In s-IBM, expression of myogenic regulatory factors and
markers of regeneration was not related to the degree of
abnormal protein accumulation. Disease duration or age
of s-IBM patients at the time of biopsy had no inﬂuence
on any of the variables. Muscle from s-IBM patients who
had received immunomodulatory treatment before biopsy
showed a lower percentage of MHC-I positive muscle
ﬁbers (p = 0.019) and reduced inﬁltration by CD8+ T-cells
(p = 0.026), while values of CD4+ T-cells and CD68+
mononuclear cells did not diﬀer from untreated patients.
Pretreatment had no eﬀect on expression of myogenic reg-
ulatory factors and markers of myo-regeneration or depo-
sition of abnormal proteins.
3.4. Microvascularization
Visualization of microvessels in sections double-stained
for CD34+ and laminin revealed marked irregularities of
the capillary architecture in IMs. In s-IBM, the median
number of capillaries per mm2 was not reduced (Fig. 3A
and G), but the normal organization of 3–5 capillaries sur-
Fig. 1. Features of myo-regeneration in s-IBM. (A) Inﬂammatory lesion in s-IBM with numerous small-sized muscle ﬁbers (H&E, original magniﬁcation
(OM) 200). (B) Muscle ﬁber with rimmed vacuoles (Gomori Trichrome, OM 200). (C) TDP-43+ deposits within a vacuole. (D) Numerous Pax7+
satellite cells (arrowheads) are closely attached to muscle ﬁbers of diﬀerent sizes (OM 400). (E, F) Several small-diameter muscle ﬁbers within an
inﬂammatory lesion contain MyoD+ (E) and/or Myogenin+ (F) nuclei (arrowheads). (G) Muscle ﬁber with central Myogenin+ nuclei. (H) Abnormal ﬁber
with Myogenin+ nuclei and vacuolization of the cytoplasm (arrowhead) (C–H, OM 400). (I, J) Numerous small-diameter muscle ﬁbers in inﬂammatory
lesions in s-IBM express markers of early regeneration e.g. neonatal myosin (I) and vimentin (J) (OM 200). (K) A high proportion of muscle ﬁbers of
diﬀerent sizes in s-IBM muscle stains positive for NCAM (OM 200). (L) Sublaminar NCAM+ satellite cells and (M, N) mononuclear NCAM+ myogenic
cell covered by its own basal lamina (arrowhead); (K–N, double immunoﬂourescence for NCAM (red) and laminin (green), Dapi (blue) for nuclei; L–N
OM 630). (O) NCAM+ ﬁbers (red) in s-IBM with TDP-43+ deposits (green, arrowheads) (double-immunoﬂourescence for NCAM (red) and TDP-43
(green), OM 400).
Table 2
Semiquantitative analysis of MHC-I expression and inﬂammatory inﬁltration.
Median (Range) s-IBM PM DM MD C P-value#
MHC-I 4 (1–5) 4 (1–5) 3 (3–5) 1 (0–2) 0 (0–1) <0.0001
CD8 2 (1–4) 2 (1–3) 1 (1–2)* 1 (0–1) 0 (0–1) <0.0001
CD4 2 (1–4) 3 (2–4) 2 (1–2) 0.5 (0–2) 0 (0–1) <0.0001
CD68 3 (2–4) 3 (2–4) 2 (1–3) 1.5 (1–3) 1 (0–1) <0.0001
Table 2 shows the extent of sarcolemmal MHC-I expression and endomysial inﬁltration by CD8+ and CD4+ T-cells and CD68+ monocytes/macrophages
in muscle biopsies of patients and controls.
# P-values determined by Kruskal–Wallis-test indicate signiﬁcant diﬀerences among compared groups.
* Post-hoc analysis showed no diﬀerences among inﬂammatory myopathies except for values of CD8+ T-cells that are signiﬁcantly lower in DM versus s-
IBM (p = 0.002) and PM (p = 0.022).
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Fig. 3B) was severely disrupted. Moreover, the distance
between muscle ﬁbers and capillaries was increased at sites
of endomysial ﬁbrosis. Morphometric analysis of CD34+capillaries per mm2 showed similar results in s-IBM, MD
and controls, while the capillary density in s-IBM and
MD was higher than in PM and DM as shown in
Fig. 3G. CD34+ cells within the interstitial compartment
Fig. 2. (A–C) Percentage of nuclei expressing MFRs. Plots show median values with interquartile range. Continuous bars show signiﬁcant diﬀerences
between disease groups and controls, dotted bars demonstrate variations between disease groups. (A) Pax7+ SCs, *p < 0.0001; **p = 0.003; ***p = 0.016.
(B) MyoD+ nuclei, *p < 0.0001; **p = 0.001; ***p = 0.016; ****p < 0.0001. (C) Myogenin+ nuclei, *p < 0.0001; **p = 0.008; ***p = 0.001; ****p = 0.018. (D–
F) Percentage of muscle ﬁbers expressing markers of regeneration. (D) Neonatal myosin+ ﬁbers, *p < 0.0001; **p = 0.001; ***p = 0.042, ****p = 0.003. (E)
Vimentin+ ﬁbers, *p < 0.0001; **p = 0.031; ***p = 0.001. (F) NCAM+ ﬁbers, *p < 0.0001; **p = 0.001; ***p = 0.024. (G) Signiﬁcant correlation between the
frequency of CD68+ mononuclear cells and Pax7+ SCs (R = 0.561).
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cle compared to controls (Fig. 3H, p = 0.034).4. Discussion
Autoimmune T-cell mediated myo-cytotoxicity [5] and
myoﬁber degeneration related to intracellular accumulation
of multi-protein aggregates [7] are considered to be key
mechanisms in the multifactorial pathogenesis of s-IBM.
Muscle ﬁber damage activates compensatory myo-regener-
ation [14], but the in vitro proliferative activity of myoblasts
derived from s-IBM muscle has been shown to be reduced
suggesting that limitations in muscle repair mechanisms
might contribute to progressive muscle wasting in s-IBM
[21]. In the present study we have investigated in detail
the frequency, distribution and morphological appearance
of myogenic progenitor cells and regenerating ﬁbers in their
in vivo context in s-IBM muscle and we have explored
potential alterations related to inﬂammation or degenera-
tion. Quantitative analysis revealed signiﬁcantly elevated
numbers of Pax7+ SCs and myogenic cells containingMyoD+ and Myogenin+ nuclei in muscle specimens from
s-IBM patients indicating enhanced myo-regenerative activ-
ity in s-IBM compared with age-matched healthy individu-
als. In comparison with other IMs we found a similar
number of Pax7+ SCs in s-IBM, whereas the number of
MyoD+ myogenic cells was signiﬁcantly less frequent than
in PM. MyoD regulates the activation of quiescent Pax7+
SCs and most of Pax7/MyoD co-expressing cells subse-
quently proceed to proliferation by down-regulation of
Pax7, whereas some SCs maintain Pax7 and return to qui-
escence for replenishment of the resting SC pool [27]. Our
observations argue against a depletion of the Pax7+ SC pool
in s-IBM as a potential cause of impaired regeneration. Low
expression of MyoD in s-IBM muscle, however, might indi-
cate a delay and/or decrease of SC activation and myoblast
proliferation, which may occur as a consequence of replica-
tive senescence of SCs after repeated cycles of degeneration
and regeneration [28]. This hypothesis is in agreement with
the demonstration of signiﬁcant telomere shortening and a
reduced proliferation rate of sIBM myoblasts in vitro [21].
During muscle repair commitment of MyoD+ myoblasts
Fig. 3. CD34+ capillaries and CD34+ interstitial cells in s-IBM: (A) Disorganization of the capillary architecture in s-IBM (OM 400). (B) Regular
capillary network in a healthy individual with 3–5 capillaries (arrows) surrounding a single ﬁber (OM 400). (C) CD34+ mononuclear cell within the
interstitial space (red, arrow, OM 630). (D) Anti-laminin stain visualizing the basal lamina of muscle ﬁbers (green). (E) Cell nucleus visualized by Dapi
(arrow), (F) merged image (OM 630). (G) Density of CD34+ capillaries per mm2, *p < 0.028; **p = 0.026; ***p = 0.002; ****p = 0.002. (H) CD34+
interstitial cells per mm2, *p < 0.034.
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Myogenin, which is down-regulated shortly after cells
become incorporated into multinucleated muscle ﬁbers
[15]. In s-IBM, we have observed persistent nuclear expres-
sion of myogenin in numerous, both small and large diam-
eter muscle ﬁbers as well as vacuolated muscle ﬁbers. These
observations might reﬂect an impairment of both the diﬀer-
entiation of myoblasts [29] as well as maturation of emerg-
ing muscle ﬁbers that are apparently vulnerable to undergo
vacuolar degeneration.
Consistent with the expression pattern of myogenic reg-
ulatory factors in s-IBM, the frequency of muscle ﬁbers
expressing markers of regeneration remarkably increased
in parallel with the extent of inﬂammation providing fur-
ther evidence for a substantial attempt of spontaneous
muscle repair in s-IBM, as suggested by previous reports
[16,20]. In areas with advanced ﬁber atrophy and ﬁbrosis,
however, neonatal myosin+ and vimentin+ early regenerat-
ing ﬁbers decreased, while the number of NCAM+ ﬁbersremained high. NCAM, a cell-surface glycoprotein abun-
dant in embryonic muscle, is lost during development but
will be re-expressed in both regenerating and denervated
muscle ﬁbers [17]. Thus, the high proportion of NCAM+
ﬁbers in s-IBM muscle might result from a delay or arrest
of maturation of the newly regenerated ﬁbers which main-
tain NCAM expression and display an increased suscepti-
bility to protein aggregation as shown by the
accumulation of TDP-43 protein in these ﬁbers. Addition-
ally, modiﬁcations of innervation [30] and/or a reaction to
cellular stress [31] may contribute to the pronounced
increase of NCAM+ ﬁbers in s-IBM.
Pax7+ SCs, MyoD+ and Myogenin+ myogenic cells and
early regenerating ﬁbers preferentially co-localized with
inﬂammatory lesions and we found a close correlation
between the grade of MHC-I expression and inﬂammatory
cell inﬁltration and the extent of the expression of myo-
genic regulatory factors as well as the frequency of regener-
ating ﬁbers in all disease groups included in our study
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myo-regeneration. Muscle injury evokes an inﬂux of
CD68+ macrophages engaged in the removal of cellular
debris. Beside propagation of inﬂammation and cell lysis,
experimental observations suggest that soluble factors
released by CD68+ macrophages are also involved in the
modulation of transcriptional activities of regenerative
muscle cells [32]. Pro-inﬂammatory cytokines such as
TNF-a, IL-1b and IL-6, that are strongly expressed in
inﬂammatory myopathies [33], were reported to exert dif-
ferent eﬀects on myogenesis [32]. While TNF-a and IL-6
were shown to promote proliferation of myoblasts in the
early phase of regeneration [34,35], both TNF-a and IL-6
as well as IL-1b inhibit fusion of myogenic cells and tran-
sition to the phase of terminal diﬀerentiation via multiple
pathways such as activation of NF-jB or impairment of
insulin-like growth factor induced protein synthesis in
myoblasts [35,36]. Inﬁltration by CD68+ macrophages
was a prominent feature in all IM subtypes studied, but
the eﬀects on muscle repair may vary depending on the
stage of muscle injury. While CD68+ macrophages stimu-
late the activation and proliferation of SCs in the acute
stage of muscle damage, experimental prolongation of the
presence of CD68+ macrophages is associated with a delay
of myogenic diﬀerentiation [32]. In this sense, persistence of
CD68+ macrophages in chronic lesions of s-IBM may exert
inhibitory eﬀects on the late phase of muscle regeneration
and could in part explain the increased expression of
Myogenin we have observed in s-IBM muscle.
Suﬃcient vascularization ensuring oxygen and nutrient
supply is mandatory for the integration and survival of
newly generated muscle ﬁbers [15]. SCs organize close to
capillaries suggesting a functional relationship between
myogenesis and vasculogenesis [37]. Analyzing the density
and distribution of capillaries we demonstrate pronounced
irregularities of the microvascular architecture in s-IBM
muscle, although median numbers of microvessels per
square millimeter did not diﬀer signiﬁcantly from normal
individuals. Sites of inﬂammation and muscle regeneration
were accompanied by a focal increase of capillaries indicat-
ing vascular neo-formation in these areas. It has been
shown that sprouts of endothelial cells emanating from
pre-existing vessels may incorporate resident or circulating
endothelial progenitors cells [38], but the precise mecha-
nisms have not been elucidated. In s-IBM, the number of
mononuclear CD34+ cells within the interstitial space was
increased, in line with a previous study suggesting that cir-
culating endothelial progenitor cells can colonize skeletal
muscle in inﬂammatory conditions to support coordinated
myo-vasculogenesis [19]. In areas with endomysial ﬁbrosis,
however, capillaries appeared reduced and were detached
from muscle ﬁbers, which might lead to insuﬃcient perfu-
sion and metabolic disturbance, hypoxia and oxidative
stress in advanced stages of muscle pathology in s-IBM.
In conclusion our study demonstrates signiﬁcantly
enhancedmyo-regenerative processes in s-IBMconcomitant
to inﬂammation and vascular reorganization. AlthoughPax7+ satellite cells may increase to a similar extent as in
other inﬂammatory myopathies, an altered expression of
myogenic regulatory factors that govern activation and
diﬀerentiation of myogenic progenitor cells as well as mor-
phological abnormalities of regenerating ﬁbers suggest an
impairment of the complex regulation of myogenesis and
coordinated tissue repair in s-IBM.
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